Clinical Trials for DLBCL Activated B-Cell Type

Find clinical trials for dlbcl activated b-cell type. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Iomab-ACT: a Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

NCT ID: NCT04512716

The Iomab-ACT trial is a study looking at a new treatment approach for patients with specific types of blood cancers, including relapsed or hard-to-treat B-Cell Acute Lymphoblastic Leukemia (B-ALL)...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: New York, New York, United States, Middletown, New Jersey, United States +5 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions